CD8A and neoplasm: Vaccination with DNA expressing E7 fused to M. tuberculosis HSP70 robustly increases E7-specific CD8+ T cell responses and therapeutic antitumor effects against the E7-expressing TC-1 tumor compared to responses from vaccination with E7 DNA, HSP70 DNA, or the combination (24, 26, –, 29).